North America Antibiotics & Antimycotics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Antibiotics & Antimycotics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Antibiotics & Antimycotics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Antibiotics & Antimycotics Market Regional Analysis

6.2 North America Antibiotics & Antimycotics Market Revenue 2021-2031 (US$ Million)

6.3 North America Antibiotics & Antimycotics Market Forecast Analysis

7. North America Antibiotics & Antimycotics Market Analysis – by Drug Class

7.1 Penicillin

7.1.1 Overview
7.1.2 Penicillin: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Cephalosporines

7.2.1 Overview
7.2.2 Cephalosporines: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Carbapenems

7.3.1 Overview
7.3.2 Carbapenems: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Macrolides

7.4.1 Overview
7.4.2 Macrolides: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Aminoglycosides

7.5.1 Overview
7.5.2 Aminoglycosides: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Quinolones

7.6.1 Overview
7.6.2 Quinolones: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.7 Sulfonamides

7.7.1 Overview
7.7.2 Sulfonamides: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.8 Tetracyclines

7.8.1 Overview
7.8.2 Tetracyclines: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.9 Azoles

7.9.1 Overview
7.9.2 Azoles: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.10 Others

7.10.1 Overview
7.10.2 Others: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Antibiotics & Antimycotics Market Analysis – by Indication

8.1 Skin Infections

8.1.1 Overview
8.1.2 Skin Infections: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Respiratory Infections

8.2.1 Overview
8.2.2 Respiratory Infections: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Urinary Tract Infections

8.3.1 Overview
8.3.2 Urinary Tract Infections: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Septicemia

8.4.1 Overview
8.4.2 Septicemia: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Ear Infections

8.5.1 Overview
8.5.2 Ear Infections: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Gastrointestinal Infections

8.6.1 Overview
8.6.2 Gastrointestinal Infections: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.7 Others

8.7.1 Overview
8.7.2 Others: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Antibiotics & Antimycotics Market Analysis – by Route Of Administration

9.1 Oral

9.1.1 Overview
9.1.2 Oral: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Topical

9.2.1 Overview
9.2.2 Topical: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Others

9.3.1 Overview
9.3.2 Others: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Antibiotics & Antimycotics Market Analysis – by Distribution Channel

10.1 Hospital Pharmacies

10.1.1 Overview
10.1.2 Hospital Pharmacies: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Retail Pharmacies

10.2.1 Overview
10.2.2 Retail Pharmacies: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Online Pharmacies

10.3.1 Overview
10.3.2 Online Pharmacies: North America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. North America Antibiotics & Antimycotics Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Antibiotics & Antimycotics Market Breakdown, by Key Country, 2024 and 2031 (%)
11.2.1.1 North America Antibiotics & Antimycotics Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Antibiotics & Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 US: North America Antibiotics & Antimycotics Market Breakdown, by Drug Class
11.2.1.1.2 US: North America Antibiotics & Antimycotics Market Breakdown, by Indication
11.2.1.1.3 US: North America Antibiotics & Antimycotics Market Breakdown, by Route Of Administration
11.2.1.1.4 US: North America Antibiotics & Antimycotics Market Breakdown, by Distribution Channel

11.2.1.2 Canada: North America Antibiotics & Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 Canada: North America Antibiotics & Antimycotics Market Breakdown, by Drug Class
11.2.1.2.2 Canada: North America Antibiotics & Antimycotics Market Breakdown, by Indication
11.2.1.2.3 Canada: North America Antibiotics & Antimycotics Market Breakdown, by Route Of Administration
11.2.1.2.4 Canada: North America Antibiotics & Antimycotics Market Breakdown, by Distribution Channel

11.2.1.3 Mexico: North America Antibiotics & Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 Mexico: North America Antibiotics & Antimycotics Market Breakdown, by Drug Class
11.2.1.3.2 Mexico: North America Antibiotics & Antimycotics Market Breakdown, by Indication
11.2.1.3.3 Mexico: North America Antibiotics & Antimycotics Market Breakdown, by Route Of Administration
11.2.1.3.4 Mexico: North America Antibiotics & Antimycotics Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Pfizer Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Novartis AG

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Sanofi SA

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 F. Hoffmann-La Roche Ltd

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Merck & Co Inc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 GSK Plc

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Johnson & Johnson

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Cipla Ltd

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Bayer AG

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 AbbVie Inc

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Astellas Pharma Inc

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Antibiotics & Antimycotics Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis